+72.9%
GSK vs ROIV
+267.7%
-194.9%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | ROIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -2.3% | +2.2% | 0.0% |
| 7D | -1.3% | -5.1% | +3.8% | -1.1% |
| 30D | +2.7% | +15.2% | -12.4% | +2.2% |
| 3M | +2.7% | +6.7% | -3.9% | +2.4% |
| 6M | +3.3% | +31.8% | -28.5% | +2.1% |
| YTD | +6.5% | +77.9% | -71.5% | +4.1% |
| 1Y | +10.7% | +90.3% | -79.6% | +8.0% |
| 3Y | +64.4% | +328.0% | -263.7% | +57.1% |
| 5Y | +46.7% | +370.9% | -324.2% | +35.8% |
| All | +72.9% | +267.7% | -194.9% | +56.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ROIV.
Daily Out/Under-Performance
Portfolio return minus ROIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ROIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded ROIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling